Notoginsenoside Fc ( —— )

产品货号. M19221 CAS No. 88122-52-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Notoginsenoside Fc
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

三七皂苷Fc具有完善的抗血小板聚集作用。
产品描述

Notoginsenoside Fc has perfect anti-platelet aggregatory effect.
体外实验

Notoginsenoside Fc (20 μM; for 24?h) markedly upregulates the expression of LC3B and Beclin 1 and downregulated that of p62 in RAOECs.
体内实验

Notoginsenoside Fc (3.5?mg/kg/day) accelerates reendothelialization and alleviates excessive neointimal formation following carotid artery injury in diabetic Sprague-Dawley rats (200±20?g) in vivo.
同义词

——
通路

Others
靶点

Other Targets
受体

Others
研究领域

——
适应症

——

CAS Number

88122-52-5
分子量

1211.38
分子式

C58H98O26
纯度

>98% (HPLC)
溶解度

In Vitro:?DMSO : 100 mg/mL (82.55 mM)
SMILES

CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)OC8C(C(C(C(O
化学全称

——

计算器

产品手册

关联产品

Galocitabine

Galocitabine (Neofrutulon), a thymidylate synthase inhibitor, is used potentially for the treatment of cancer.
Phenylalanine-free p...

Phenylalanine-free protein 115 120 125
kaempferide

Kaempferide trigluside 通过一种不由配体结合依赖性雌激素受体激活介导的机制抑制天然和雌激素受体β过度表达的结肠癌细胞的增殖。